BioSpace News Archive

BioMidwest

NCQA Rates MeridianHealth among Top-Performing Medicaid Plans in Michigan

Meridian Health Plan of Michigan, Inc., a WellCare Health Plans, Inc. company, received an overall score of 4 out of 5 in the National Committee for Quality Assurance Medicaid Health Insurance Plan Ratings 2019-2020.

October 10, 2019
·
3 min read
BioMidwest

NCQA Rates MeridianHealth among Top-Performing Medicaid Plans in Illinois

Meridian Health Plan of Illinois, Inc., a WellCare Health Plans, Inc. company, rated among the top Medicaid plans in the state, according to the National Committee for Quality Assurance Medicaid Health Insurance Plan Ratings 2019-2020.

October 10, 2019
·
3 min read
Business

DelMar Pharmaceuticals to Present at the Inaugural MicroCap Rodeo Investor Conference on October 15, 2019 at 11:30 AM Central Time

Mr. Zarrabian will provide an overview of the Company’s business model and growth strategy and will be available for one-on-one meetings.

October 10, 2019
·
3 min read
Pharm Country

TrialScout™ Goes Global with hyperCORE International Partnership

TrialScout™ announced today that hyperCORE International has joined its powerful and dynamic platform that aims to help patients find clinical trials and choose the research site that is right for them

October 10, 2019
·
3 min read
Business

Vantage EyeCare, LLC at 2019 American Academy of Ophthalmology Annual Meeting

The physicians and surgeons of Vantage EyeCare, LLC will be out in force at the American Academy of Ophthalmology’s Annual Meeting in San Francisco, October 11 – 15, 2019, sharing their expertise and learning from their peers.

October 10, 2019
·
3 min read
Business

UCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravis and Other Rare Diseases

UCB and Ra Pharmaceuticals Inc. announced their entry into a merger agreement pursuant for which UCB will acquire Ra Pharma.

October 10, 2019
·
16 min read
Tej Kohli Foundation advocates a scalable, accessible and affordable technology solution to end corneal blindness worldwide.

Says game-changing biotechnology solutions are needed to accelerate a global mission to eradicate ‘needless’ corneal blindness.

October 10, 2019
·
5 min read
Drug Development

Galderma Advances Phase 3 Clinical Study with Nemolizumab in Moderate-to-Severe Atopic Dermatitis

Galderma announced that it has enrolled the first patients in a new Phase 3 clinical study with nemolizumab, an investigational therapy in adult patients with moderate-to-severe atopic dermatitis.

October 10, 2019
·
3 min read
Drug Development

US National Cancer Institute Initiates Phase I Study of Treatment of Head and Neck Cancer Patients With Medivir’s Birinapant and Radiation Therapy

Medivir AB announces that the first patient has been enrolled in a phase I study to investigate the safety and tolerability of a combination treatment of birinapant and radiation therapy in patients with recurrent Head and Neck Squamous Cell Carcinoma.

October 10, 2019
·
3 min read
BIA Separations introduces CORNERSTONE Exosome Process Development Solution to Enable Industrial Scale Manufacture of Therapeutic Exosomes

BIA Separations announced the introduction of its CORNERSTONE Exosome Process Development Solution, designed to help drug-developers overcome critical development bottlenecks in the preparation of exosomes for clinical use.

October 10, 2019
·
3 min read